Purchase Order 15B51926P00000042
- Not listed
- McKesson Corporation, a major pharmaceutical distribution and healthcare services provider headquartered in Irving, Texas, was awarded a firm fixed-price purchase order valued at $2,569.35 by the Federal Correctional Complex Pollock on July 23, 2025. The contract, which carries an ultimate completion date of August 6, 2025, covers pharmaceutical products and is classified as a non-competed award with no set-aside designation. The place of performance is Irving, Texas, where McKesson maintains...
- The Department of Justice Bureau of Prisons Federal Correctional Complex Pollock awarded McKesson Corporation a firm fixed price purchase order valued at approximately $1,291 for pharmaceutical products. McKesson will provide the pharmaceuticals to the Bureau of Prisons facility in Irving, Texas between December 21-30, 2023. As the parent company of McKesson Drug Company, McKesson Corporation will serve as the prime contractor on this contract to supply pharmaceuticals for the Federal...
- The Federal Correctional Complex Pollock, a civilian facility under the Department of Justice, awarded a purchase order to McKesson Corporation on November 19, 2025, for regular orders and vials under a firm fixed-price contract with a ceiling value of $1,355.83. This is a non-set-aside procurement, with performance to be completed by November 20, 2025, and fulfillment occurring in Irving, Texas. As a large pharmaceutical and medical supply distributor, McKesson serves as a critical vendor for...
- The Department of Justice Bureau of Prisons Federal Correctional Complex Pollock awarded McKesson Corporation a firm fixed price delivery order valued at one hundred six thousand one hundred sixty-eight dollars and fifty-four cents ($106,168.54) to provide pharmaceuticals. McKesson, doing business as McKesson Drug Company and a subsidiary of McKesson Corporation, will deliver the pharmaceutical products to the facility located in Irving, Texas between December 29, 2023 and December 31, 2023....
- McKesson Corporation was awarded a purchase order valued at $4,924.61 by the Federal Correctional Complex Pollock for medications under McKesson PO 3717. The award, issued on November 19, 2025, represents a firm fixed-price purchase order with no set-aside designation. The contract will be performed at McKesson's location in Irving, Texas, and is scheduled for completion by November 20, 2025. As the primary pharmaceutical and medical supply vendor for the Bureau of Prisons, McKesson provides...
- Mckesson Corporation will deliver pharmaceuticals to the Federal Correctional Complex Pollock under a $1,881.57 firm fixed price purchase order awarded by the Department of Justice Bureau of Prisons (DOJ-BOP). Performance will occur in Irving, Texas over a one-day period concluding on August 31, 2023. As one of the largest federal correctional facilities, FCC Pollock houses over 5,000 inmates and likely utilizes significant pharmaceutical supplies to support daily medical operations. No...
- Mckesson Corporation will deliver pharmaceuticals to the Federal Correctional Complex Pollock under a $65,699.75 firm fixed price delivery order awarded by the Department of Justice Bureau of Prisons (DOJ-BOP). Performance will take place in Irving, Texas from September 18-30, 2023. As a leading distributor of pharmaceutical and medical supplies, Mckesson will utilize its existing contracts with DOJ-BOP to provide needed medications to the 1,836 inmate facility in Pollock, Louisiana as part of...
- The Federal Correctional Complex Pollock, a civilian facility within the Bureau of Prisons, awarded a firm fixed-price purchase order valued at $3,034.19 to McKesson Corporation on November 19, 2025, with an ultimate completion date of November 20, 2025. The contract, designated as Open Market Purchase Order 3715, contains no set-aside provisions and will be performed in Irving, Texas. McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered...
- McKesson Corporation was awarded a firm fixed-price purchase order valued at $6,173.77 for pharmaceutical products by the Federal Correctional Complex Pollock, a civilian facility within the Bureau of Prisons. The award was issued on August 7, 2025, with an ultimate completion date of August 21, 2025, and reflects no set-aside designation. The place of performance is Irving, Texas, where McKesson maintains its headquarters. This purchase order represents a routine pharmaceutical supply...
- The Department of Justice Bureau of Prisons Federal Correctional Complex Pollock awarded McKesson Corporation a $67,863 delivery order contract to provide pharmaceuticals. As the prime contractor, McKesson will deliver pharmaceutical products to support the Bureau of Prisons facility in Pollock, Louisiana under a firm fixed price arrangement. The single award is for performance from August 28 through September 30, 2023 and utilizes no set aside designations. McKesson will fulfill the order...
The Federal Correctional Complex Pollock awarded a $20,030.93 firm fixed-price purchase order to McKesson Corporation for regular medications (REGULAR MEDS PO 3712) with an ultimate completion date of November 17, 2025. This is a civilian contract with no set-aside designation, reflecting McKesson's status as a large business contractor. The place of performance is Irving, Texas, where McKesson maintains its corporate headquarters and primary pharmaceutical distribution operations. McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company, serves as a critical medical supply vendor for the Bureau of Prisons, which operates the Federal Correctional Complex Pollock facility. The contract delivers controlled and non-controlled medications essential for inmate healthcare operations within the correctional facility. McKesson's extensive experience providing pharmaceutical and medical supplies to federal correctional institutions, combined with its significant Blanket Purchase Agreements across multiple federal agencies including the Department of Homeland Security and Department of Veterans Affairs, positions the company as a primary healthcare logistics provider for federal government operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $20.0k | 12/10/25 | |
| Not listed | Not listed | $0 | 11/14/25 |